NAS:HOLX (USA) Also trade in: Austria Germany UK

Hologic Inc

$ 44.69 0.01 (0.02%)
Volume: 845,505 Avg Vol (1m): 1,465,025
Market Cap $: 11.98 Bil Enterprise Value $: 14.71 Bil
P/E (TTM): 0.00 P/B: 5.57
Earnings Power Value 11.44
Net Current Asset Value -10.6
Tangible Book -8.47
Projected FCF 23.7
Median P/S Value 35.34
Graham Number 0
Peter Lynch Value 0.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.13
Cash-To-Debt ranked lower than
85.37% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
HOLX: 0.13
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 1.91, Max: 10000
Current: 0.13
0.04
10000
Equity-to-Asset 0.33
Equity-to-Asset ranked lower than
76.53% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
HOLX: 0.33
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.02, Med: 0.68, Max: 0.88
Current: 0.33
0.02
0.88
Debt-to-Equity 1.45
Debt-to-Equity ranked lower than
85.21% of 142 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
HOLX: 1.45
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.28, Max: 10
Current: 1.45
0
10
Debt-to-EBITDA 5.77
Debt-to-EBITDA ranked higher than
51.38% of 109 companies
in the Medical Instruments & Supplies industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
HOLX: 5.77
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -12.14, Med: 3.59, Max: 15.81
Current: 5.77
-12.14
15.81
Interest Coverage 0.93
Interest Coverage ranked lower than
75.91% of 137 companies
in the Medical Instruments & Supplies industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
HOLX: 0.93
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1, Med: 2.38, Max: 3.6
Current: 0.93
1
3.6
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.70
DISTRESS
GREY
SAFE
Beneish M-Score -2.80
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 0.37%
WACC 6.75%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 3.97
Operating Margin ranked higher than
97.01% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
HOLX: 3.97
Ranked among companies with meaningful Operating Margin only.
N/A
Net Margin % -0.32
Net Margin ranked higher than
95.02% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
HOLX: -0.32
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -135.4, Med: -1.39, Max: 24.7
Current: -0.32
-135.4
24.7
ROE % -0.45
ROE ranked higher than
95.96% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
HOLX: -0.45
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -60.17, Med: -0.73, Max: 30.67
Current: -0.45
-60.17
30.67
ROA % -0.15
ROA ranked higher than
87.38% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
HOLX: -0.15
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -32.08, Med: -0.35, Max: 9.88
Current: -0.15
-32.08
9.88
ROC (Joel Greenblatt) % 8.44
ROC (Joel Greenblatt) ranked higher than
99.02% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
HOLX: 8.44
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -369.68, Med: 25.23, Max: 208.04
Current: 8.44
-369.68
208.04
3-Year Total Revenue Growth Rate 6.00
3-Year Revenue Growth Rate ranked higher than
54.71% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
HOLX: 7.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -14.1, Med: 8.8, Max: 41.9
Current: 7.8
-14.1
41.9
3-Year Total EBITDA Growth Rate -37.80
3-Year EBITDA Growth Rate ranked higher than
78.71% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 426.6, Med: 10, Min: -759
HOLX: -36.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
N/A

» HOLX's 30-Y Financials

Financials (Next Earnings Date: 2019-07-31)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:HOLX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 334517    SIC : 3844
Compare XSWX:STMN XSWX:SOONE NYSE:TFX NYSE:COO NYSE:VAR NYSE:RMD TSE:7733 NAS:XRAY NYSE:STE NYSE:WST XTER:AFX OCSE:DEMANT NAS:MASI NYSE:HRC TSE:7747 NZSE:FPH TSE:4543 NAS:ICUI NYSE:HAE OSTO:EKTA B
Traded in other countries HO1.Germany 0J5Q.UK
Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic Inc manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (47% of sales), breast health (37%), surgical (12%), and skeletal health (4%). While the company traditionally focused on breast health, the recent acquisition of Gen-Probe puts a much greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%) and Asia (8%). Hologic is headquartered in Bedford, Massachusetts.

Ratios

Current vs industry vs history
Forward PE Ratio 18.55
Forward P/E ranked higher than
90.00% of 40 companies
in the Medical Instruments & Supplies industry.
Industry Max: 80, Med: 26.32, Min: 12.3
HOLX: 18.55
Ranked among companies with meaningful Forward P/E only.
N/A
Price-to-Owner-Earnings 138.79
Price-to-Owner-Earnings ranked higher than
78.31% of 83 companies
in the Medical Instruments & Supplies industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
HOLX: 138.79
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 8.31, Med: 22.95, Max: 150.31
Current: 138.79
8.31
150.31
PB Ratio 5.57
PB Ratio ranked higher than
50.78% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
HOLX: 5.57
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.59, Med: 2.98, Max: 6.03
Current: 5.57
0.59
6.03
PS Ratio 3.70
PS Ratio ranked lower than
52.60% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
HOLX: 3.7
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.47, Med: 2.93, Max: 4.6
Current: 3.7
1.47
4.6
Price-to-Free-Cash-Flow 20.48
Price-to-Free-Cash-Flow ranked lower than
100.00% of 74 companies
in the Medical Instruments & Supplies industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
HOLX: 20.48
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 6.52, Med: 14.84, Max: 26.28
Current: 20.48
6.52
26.28
Price-to-Operating-Cash-Flow 17.31
Price-to-Operating-Cash-Flow ranked lower than
100.00% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
HOLX: 17.31
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.51, Med: 13.09, Max: 928.86
Current: 17.31
5.51
928.86
EV-to-EBIT 219.89
EV-to-EBIT ranked higher than
90.91% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
HOLX: 219.89
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -58.7, Med: 24.1, Max: 235.6
Current: 219.89
-58.7
235.6
EV-to-EBITDA 27.10
EV-to-EBITDA ranked higher than
89.86% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
HOLX: 27.1
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -32.4, Med: 13.1, Max: 73.9
Current: 27.1
-32.4
73.9
EV-to-Revenue 4.48
EV-to-Revenue ranked lower than
57.79% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
HOLX: 4.48
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 2.6, Med: 4.2, Max: 5.8
Current: 4.48
2.6
5.8
Current Ratio 1.45
Current Ratio ranked lower than
83.00% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
HOLX: 1.45
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.79, Med: 2.75, Max: 7.31
Current: 1.45
0.79
7.31
Quick Ratio 1.02
Quick Ratio ranked lower than
78.11% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
HOLX: 1.02
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.61, Med: 2.18, Max: 6.57
Current: 1.02
0.61
6.57
Days Inventory 73.95
Days Inventory ranked higher than
74.11% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
HOLX: 73.95
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 72.07, Med: 86.95, Max: 108.2
Current: 73.95
72.07
108.2
Days Sales Outstanding 61.92
Days Sales Outstanding ranked lower than
52.73% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
HOLX: 61.92
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 56.15, Med: 60.73, Max: 74.61
Current: 61.92
56.15
74.61
Days Payable 30.87
Days Payable ranked lower than
64.90% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
HOLX: 30.87
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 21.81, Med: 29.16, Max: 46.12
Current: 30.87
21.81
46.12

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 1.50
3-Year Share Buyback Rate ranked higher than
84.62% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
HOLX: 1.5
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -53.1, Med: -5.9, Max: 1.5
Current: 1.5
-53.1
1.5

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.88
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
68.00% of 75 companies
in the Medical Instruments & Supplies industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
HOLX: 1.88
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.45, Med: 1.74, Max: 13.86
Current: 1.88
0.45
13.86
Price-to-Median-PS-Value 1.26
Price-to-Median-PS-Value ranked lower than
56.88% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
HOLX: 1.26
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.15, Med: 0.84, Max: 2.58
Current: 1.26
0.15
2.58
Earnings Yield (Joel Greenblatt) % 0.45
Earnings Yield (Greenblatt) ranked higher than
94.69% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
HOLX: 0.45
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -49.1, Med: 2.5, Max: 10.6
Current: 0.45
-49.1
10.6
Forward Rate of Return (Yacktman) % 21.32
Forward Rate of Return ranked higher than
92.08% of 101 companies
in the Medical Instruments & Supplies industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
HOLX: 21.32
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 4.8, Med: 6.9, Max: 25.4
Current: 21.32
4.8
25.4

More Statistics

Revenue (TTM) (Mil) $ 3,286.5
EPS (TTM) $ -0.06
Beta 0.95
Volatility % 23.83
52-Week Range $ 37.47 - 48.82
Shares Outstanding (Mil) 268.05

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y